Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Online Sleep Course for Public Safety Personnel

Official title: Uptake, Acceptability, and Effectiveness of Internet-Delivered Cognitive Behavioural Therapy for Public Safety Personnel With Self-Reported Sleep Difficulties

Run by University of Regina · NCT07021183 · Data updated 2026-11-12

This online cognitive behavioural therapy sleep course tests whether it helps public safety personnel (e.g., firefighters, paramedics, police, correctional workers) who have insomnia.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorUniversity of Regina
Academic / other
Locations1 site (Regina, Saskatchewan)
StatusRecruiting
StartedMarch 6, 2025
Main results expectedMarch 31, 2028
Study endsMarch 31, 2028
Registry record updatedSeptember 4, 2026
Trial IDNCT07021183 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) who are current or former paid or volunteer public safety personnel, live in a Canadian province where PSPNET offers the Sleep Course during the treatment period, have internet access, and can read English and consent to online therapy.

Probably not a fit

People with current severe psychiatric or medical disorders (e.g., active psychosis, recent hospitalization, active suicidality), those without internet access or English literacy, or those living outside the provinces where PSPNET offers the course are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study offers an internet-delivered cognitive behavioural therapy for insomnia (ICBTi) program called the Sleep Course that has been adapted for public safety personnel (PSP). The program is delivered online through PSPNET over a series of modules and can be offered with or without therapist support, requiring participants to have internet access and English literacy. The trial aims to replicate results from an earlier Australian version by measuring changes in sleep symptoms and the acceptability of the course among PSP. Eligibility excludes people with current severe medical or psychiatric disorders that would interfere with treatment.

Why it matters

Potential benefit: If successful, the program could improve sleep quality and daytime functioning for PSP while increasing access to evidence-based insomnia care for shift workers.

How similar studies have gone: Prior research supports ICBTi for insomnia and the Australian version of the Sleep Course reported positive outcomes and acceptability, which this study seeks to replicate for PSP.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years of age or older
* Canada resident
* Trainee, staff, or retired public safety personnel (PSP)
* Willingness to learn information and skills to manage sleep difficulties
* Have internet access
* Consent to the PSP Sleep Course

Exclusion Criteria:

* Current severe medical or psychiatric disorder (e.g. current and recent mania or psychosis, recent hospitalization for mental health concerns, actively suicidal, medical condition client thinks will interfere with treatment, severe substance use)
* Unable to read and understand English. (All content is provided in English and staff is English speaking; pending findings of the research PSPNET will explore translating the course into French)

Where it's running

  • University of Regina
    Regina, Saskatchewan, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.